Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Hussein Yassine, MD

    TitleAssistant Professor of Medicine
    SchoolKeck School of Medicine of USC
    DepartmentMedicine
    AddressCSC 210
    Health Sciences Campus
    Los Angeles California 90089-9073
    Phone+1 323 442 1909
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Yassine is an Assistant Professor of Medicine-Endocrinology at the University of Southern California and was mentored by Dr. Serrine Lau. Dr. Yassine graduated from Beirut Arab University in June 2003 with his MD. He completed residency training in Internal Medicine at Case Western Reserve University, and graduated in June 2007. Dr. Yassine was awarded the prestigious “Resident Teacher of the Year” at graduation. Dr. Yassine was awarded the “Presidential Poster Award” (2009) from the Endocrine Society for research on platelet function in diabetes. Dr. Yassine was co-mentored by additional SWEHSC members including Drs. Craig Stump (Endocrinology, clinical expertise), Dean Billheimer (Biostatistics, proteomics and population analysis) and Donata Vercelli (Advisor, clinical and genetics expertise).

      Dr. Yassine's long term research program focuses on the contribution of dyslipidemia to atherosclerosis. He completed his post-doctoral training in the Lau Lab (2010) in the application of mass spectrometry to study proteins and protein modifications relevant to diabetes and cardiovascular disease. He joined the faculty at the University of Arizona and established the lipid clinic. With this exposure, he developed an understanding of the unmet clinical needs in lipids and cardiovascular disease. To that end, he obtained a career development award from NIH K23 grant HL107389, entitled "Effect of Saturated Fat on HDL Proteome, " with Dr. Serrine Lau as his main mentor. and an AHA clinical research award to study HDL protein composition by mass spectrometry in diabetes.

      In 2009 Dr. Yassine served as a key personnel on a SWEHSC Pilot project grant (PI-Stump) to study the role of arsenic exposure on diabetes development and complications. Dr. Yassine was mentored by Drs. Lau and Tsaprailis on the utilization of mass spectrometry-based proteomics approaches in determining protein biomarkers associated with Type 2 Diabetes and the association of arsenic exposure and diabetes development. In addition to providing mentors from all disciplines, secretarial, and computer support, the SWEHSC was a platform for promoting interactions with Drs. Randy Nelson and Peter Reaven, established investigators in diabetes projects at the Biodesign Institute of ASU, and the Phoenix VA Medical Center, respectively. These interactions resulted in Dr. Yassine serving as a co-Investigator on a NIH R01 application titled “Population Proteomics of Type 2 Diabetes” led by Dr. Nelson. He moved to the University of Southern California in September 2012 to establish his own laboratory.


      Collapse Biography 
      Collapse Awards and Honors
      Beirut Arab University, Beirut, Lebanon 2002Dean's Distinguished Student Medicine Day Award
      Beirut Arab University, Beirut, Lebanon 2003Dean's Honor List on graduation
      Case Western Reserve University, Cleveland, OH 2007Resident Teacher of the Year Award
      2009Department of Veterans Affairs VISN 18 Outstanding Research Award
      2009Presidential Poster Award, Endocrine Society

      Collapse ORNG Applications 
      Collapse Websites
      Collapse Required Scholarly Project Mentor

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Yassine H, Croteau E, Rawat V, Hibbeln JR, Rapoport SI, Cunnane SC, Umhau JC. DHA brain uptake and APOE4 status: a PET study with [1-11C]-DHA. Alzheimers Res Ther. 2017 Mar 23; 9(1):23. PMID: 28335828.
        View in: PubMed
      2. Yassine H, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E e4 Carriers: A Review. JAMA Neurol. 2017 Jan 17. PMID: 28114437.
        View in: PubMed
      3. Mendoza S, Trenchevska O, King SM, Nelson RW, Nedelkov D, Krauss RM, Yassine H. Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions. J Clin Lipidol. 2017 Jan - Feb; 11(1):224-233.e2. PMID: 28391889.
        View in: PubMed
      4. Yassine H, Feng Q, Azizkhanian I, Rawat V, Castor K, Fonteh AN, Harrington MG, Zheng L, Reed BR, DeCarli C, Jagust WJ, Chui HC. Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis. JAMA Neurol. 2016 Oct 1; 73(10):1208-1216. PMID: 27532692.
        View in: PubMed
      5. Trenchevska O, Yassine H, Borges CR, Nelson RW, Nedelkov D. Development of quantitative mass spectrometric immunoassay for serum amyloid A. Biomarkers. 2016 Jul 22; 1-9. PMID: 27308834.
        View in: PubMed
      6. Yassine H, Rawat V, Mack WJ, Quinn JF, Yurko-Mauro K, Bailey-Hall E, Aisen PS, Chui HC, Schneider LS. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease. Alzheimers Res Ther. 2016; 8:25. PMID: 27358067.
        View in: PubMed
      7. Yassine H, Trenchevska O, Dong Z, Bashawri Y, Koska J, Reaven PD, Nelson RW, Nedelkov D. The association of plasma cystatin C proteoforms with diabetic chronic kidney disease. Proteome Sci. 2016; 14:7. PMID: 27019641.
        View in: PubMed
      8. Azizkhanian I, Trenchevska O, Bashawri Y, Hu J, Koska J, Reaven PD, Nelson RW, Nedelkov D, Yassine H. Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes. J Clin Lipidol. 2016 Jul-Aug; 10(4):808-15. PMID: 27578111.
        View in: PubMed
      9. Koska J, Yassine H, Trenchevska O, Sinari S, Schwenke DC, Yen FT, Billheimer D, Nelson RW, Nedelkov D, Reaven PD. Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes. J Lipid Res. 2016 May; 57(5):894-905. PMID: 26945091.
        View in: PubMed
      10. Yassine H, Feng Q, Chiang J, Petrosspour LM, Fonteh AN, Chui HC, Harrington MG. ABCA1-Mediated Cholesterol Efflux Capacity to Cerebrospinal Fluid Is Reduced in Patients With Mild Cognitive Impairment and Alzheimer's Disease. J Am Heart Assoc. 2016; 5(2). PMID: 26873692.
        View in: PubMed
      11. Yassine H, Trenchevska O, Ramrakhiani A, Parekh A, Koska J, Walker RW, Billheimer D, Reaven PD, Yen FT, Nelson RW, Goran MI, Nedelkov D. The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides. PLoS One. 2015; 10(12):e0144138. PMID: 26633899.
        View in: PubMed
      12. Kimzey MJ, Kinsky OR, Yassine H, Tsaprailis G, Stump CS, Monks TJ, Lau SS. Site specific modification of the human plasma proteome by methylglyoxal. Toxicol Appl Pharmacol. 2015 Dec 1; 289(2):155-62. PMID: 26435215.
        View in: PubMed
      13. Yassine H, Trenchevska O, He H, Borges CR, Nedelkov D, Mack W, Kono N, Koska J, Reaven PD, Nelson RW. Serum amyloid a truncations in type 2 diabetes mellitus. PLoS One. 2015; 10(1):e0115320. PMID: 25607823.
        View in: PubMed
      14. Yassine H, Jackson AM, Reaven PD, Nedelkov D, Nelson RW, Lau SS, Borchers CH. The Application of Multiple Reaction Monitoring to Assess Apo A-I Methionine Oxidations in Diabetes and Cardiovascular Disease. Transl Proteom. 2014 Dec 1; 4-5:18-24. PMID: 25705587.
        View in: PubMed
      15. Borges CR, Rehder DS, Jensen S, Schaab MR, Sherma ND, Yassine H, Nikolova B, Breburda C. Elevated Plasma Albumin and Apolipoprotein A-I Oxidation under Suboptimal Specimen Storage Conditions. Mol Cell Proteomics. 2014 Jul; 13(7):1890-9. PMID: 24736286.
        View in: PubMed
      16. Yassine H, Belopolskaya A, Schall C, Stump CS, Lau SS, Reaven PD. Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes. Metabolism. 2014 May; 63(5):727-34. PMID: 24636347.
        View in: PubMed
      17. Yassine H, Jackson AM, Borges CR, Billheimer D, Koh H, Smith D, Reaven P, Lau SS, Borchers CH. The application of multiple reaction monitoring and multi-analyte profiling to HDL proteins. Lipids Health Dis. 2014; 13(1):8. PMID: 24397693.
        View in: PubMed
      18. Yassine H, Borges CR, Schaab MR, Billheimer D, Stump C, Reaven P, Lau SS, Nelson R. Mass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetes. Proteomics Clin Appl. 2013 Aug; 7(7-8):528-40. PMID: 23696124.
        View in: PubMed
      19. Kastoon T, Stump CS, Thomson SP, Yassine H. Erlotinib-associated exacerbation of hypothyroidism with pericardial tamponade. Endocr Pract. 2012 Sep-Oct; 18(5):e111-3. PMID: 22440982.
        View in: PubMed
      20. Yassine H, Kimzey MJ, Galligan MA, Gandolfi AJ, Stump CS, Lau SS. Adjusting for Urinary Creatinine Overestimates Arsenic Concentrations in Diabetics. Cardiorenal Med. 2012 Feb; 2(1):26-32. PMID: 22493600.
        View in: PubMed
      21. Yassine H, Davis-Gorman G, Stump CS, Thomson SS, Peterson J, McDonagh PF. Effect of glucose or fat challenge on aspirin resistance in diabetes. Int J Endocrinol. 2010; 2010:820876. PMID: 21318184.
        View in: PubMed
      22. Kimzey MJ, Yassine H, Riepel BM, Tsaprailis G, Monks TJ, Lau SS. New site(s) of methylglyoxal-modified human serum albumin, identified by multiple reaction monitoring, alter warfarin binding and prostaglandin metabolism. Chem Biol Interact. 2011 Jun 30; 192(1-2):122-8. PMID: 20934417.
        View in: PubMed
      23. Yassine H, Davis-Gorman G, Stump CS, Thomson SS, Peterson J, McDonagh PF. Clinical determinants of aspirin resistance in diabetes. Diabetes Res Clin Pract. 2010 Oct; 90(1):e19-21. PMID: 20719400.
        View in: PubMed
      24. Yassine H, Marchetti CM, Krishnan RK, Vrobel TR, Gonzalez F, Kirwan JP. Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults--a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2009 Jan; 64(1):90-5. PMID: 19164269.
        View in: PubMed
      Hussein's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department